PER1 and metastatic malignant neoplasm in the lymph nodes: PER1 is decreased in squamous cell carcinoma [63,64] and low expression of PER1 is closely related to unfavorable clinical behavior, such as developed lymph node metastasis and advanced clinical stage [64,65], and poor survival [66].